Market Segmentation:
- By Product Type
- Passive Approximators
- Active Approximators
- Extravascular Closure Devices
- Accessory Devices
- Others (Sealants, Plugs, etc.)
- By Technique
- Suture-Based
- Clip-Based
- Collagen-Based
- Sealant-Based
- Others (Plugs, Patches, etc.)
- By Procedure
- Interventional Cardiology
- Interventional Radiology
- Vascular Surgery
- Others (Neurology, Endovascular Procedures, etc.)
- By Access Site
- Femoral
- Radial
- Brachial
- Others (Pedal, Carotid, etc.)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Catheterization Labs
- Others (Specialized Clinics, Research Institutes, etc.)
- By Material
- Metals
- Polymers
- Collagen
- Bioresorbable Materials
- Others (Composites, Ceramics, etc.)
- By Usage
- Disposable
- Reusable
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Arteriotomy Closure Devices industry is approximately USD 727 million.
Increasing prevalence of cardiovascular diseases, Rising minimally invasive procedures, Aging population worldwide, Technological advancements, Increasing healthcare expenditure, Favorable reimbursement policies, Growing demand for outpatient procedures, Expansion of indications, Strategic collaborations and partnerships, Increasing adoption in ambulatory settings.
Risk of complications, Product recalls and safety concerns, Stringent regulatory approvals, Reimbursement and cost issues, Lack of awareness in developing regions, Availability of alternative treatment options, Pricing pressure and competition.
The leading component segment in the Arteriotomy Closure Devices Market is the extravascular closure devices segment, designed for secure closure and reducing complications.
The major players operating in the Arteriotomy Closure Devices Market are Abbott Vascular, Terumo Corporation, Cardinal Health, Medtronic, Merit Medical Systems, and others mentioned in the previous response.
The global Arteriotomy Closure Devices Market falls under the medical devices industry and is projected to reach US$ 1,267.9 Million by 2031, driven by a robust CAGR of 7.2% during the forecast period.
Increasing cardiovascular diseases, Rising minimally invasive procedures, Aging population worldwide, Technological advancements, Increasing healthcare expenditure, Favorable reimbursement policies, Growing demand for outpatient procedures, Expansion of indications.